Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis
出版年份 2016 全文链接
标题
Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 2, Pages 519
出版商
Baishideng Publishing Group Inc.
发表日期
2016-01-18
DOI
10.3748/wjg.v22.i2.519
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer
- (2015) Eran Sadot et al. ANNALS OF SURGERY
- Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy
- (2015) Francesca Ratti et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial
- (2015) Takehiro Kato et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
- (2015) Izuma Nakayama et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens
- (2015) Stéphanie Truant et al. HPB
- Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?
- (2015) Dhanwant Gomez et al. HPB
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)
- (2014) M. Yoshida et al. ANNALS OF ONCOLOGY
- Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205
- (2014) Yasuhiro Shimada et al. EUROPEAN JOURNAL OF CANCER
- PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
- (2014) Lee S. Schwartzberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases
- (2014) Karim M. Eltawil et al. JOURNAL OF SURGICAL ONCOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
- (2014) John Primrose et al. LANCET ONCOLOGY
- Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times?
- (2014) Hong Kwan Kim WORLD JOURNAL OF GASTROENTEROLOGY
- Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
- (2014) Jon-Helge Angelsen et al. World Journal of Surgical Oncology
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
- (2013) Andreas Andreou et al. ANNALS OF SURGERY
- Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases
- (2013) Giovanni Brandi et al. Clinical Colorectal Cancer
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
- (2013) Bernard Nordlinger et al. LANCET ONCOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials
- (2013) H. I. Hurwitz et al. ONCOLOGIST
- Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
- (2012) Andreas A. Schnitzbauer et al. ANNALS OF SURGERY
- Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases in Patients at High Risk of Hepatic Recurrence
- (2012) Diane Goéré et al. ANNALS OF SURGERY
- Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
- (2012) Daniel J. Sargent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
- (2012) Aimery de Gramont et al. LANCET ONCOLOGY
- Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases
- (2012) Giovanni Brandi et al. LANGENBECKS ARCHIVES OF SURGERY
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer
- (2012) Nedim Turan et al. ONCOLOGY
- Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer
- (2011) Michael G. House et al. ANNALS OF SURGERY
- Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
- (2011) Ninos Ayez et al. ANNALS OF SURGICAL ONCOLOGY
- Patterns of Recurrence After Ablation of Colorectal Cancer Liver Metastases
- (2011) T. Peter Kingham et al. ANNALS OF SURGICAL ONCOLOGY
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis
- (2011) Hye Ryun Kim et al. ONCOLOGY
- A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
- (2010) Nikol Snoeren et al. BMC CANCER
- Adjuvant oxaliplatin- or irinotecan-containing chemotherapy improves overall survival following resection of metachronous colorectal liver metastases
- (2010) Jin-Hwang Liu et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66
- (2010) Steven R. Alberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer
- (2010) Nancy E. Kemeny et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
- (2010) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases
- (2010) T. Peter Kingham et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases
- (2010) Ralf Konopke et al. LIVER INTERNATIONAL
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
- (2009) M. Ychou et al. ANNALS OF ONCOLOGY
- A Randomized Phase II/III Trial Comparing Hepatectomy Followed by mFOLFOX6 with Hepatectomy Alone as Treatment for Liver Metastasis from Colorectal Cancer: Japan Clinical Oncology Group Study JCOG0603
- (2009) Y. Kanemitsu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
- (2009) Daniel Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Resected colorectal liver metastases: Does the survival differ according to postoperative chemotherapy regimen?
- (2009) Sun Young Kim et al. JOURNAL OF SURGICAL ONCOLOGY
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colorectal Liver Metastases
- (2008) Ana L. Gleisner ARCHIVES OF SURGERY
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
- (2008) Emmanuel Mitry et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
- (2008) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
- (2008) Carsten Bokemeyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of type of liver resection on the outcome of colorectal liver metastases: A case-matched analysis
- (2008) Eleonora Guzzetti et al. JOURNAL OF SURGICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now